Cellworks
AI-powered drug discovery and personalized therapy platform using computational biology and machine learning to accelerate therapeutic development and enable precision medicine.
Website
https://cellworks.lifeLocation
San Jose, California, USA
Founded
2011
Investors
1
Categories
ai-drug-discovery, drug-development-platform, personalized-therapy-platform, computational-biology
Notes
Cellworks is a computational biology company leveraging artificial intelligence and machine learning to accelerate drug discovery and enable personalized therapy selection. Their platform creates digital twins of patient tumors using genomic data, enabling in silico simulation of drug responses.
The company's Cellworks Singula platform helps oncologists identify optimal treatment strategies for individual cancer patients, while their drug discovery platform accelerates the identification and validation of novel therapeutic targets.
Team
- Yatin Mundkur - Chief Executive Officer
- LinkedIn: linkedin.com/in/yatinmundkur
- Shireen Vali, Ph.D. - Chief Scientific Officer
Additional Research Findings
- Backed by Artiman Ventures
- Cellworks Singula platform for personalized oncology
- AI/ML-powered computational biology platform
- Digital twin technology for cancer treatment
- Drug discovery and development capabilities
- Headquarters in San Jose, California
- Serves pharmaceutical and clinical oncology markets
Sources
Investors
| Name | Location | Type | Stages | Portfolio |
|---|---|---|---|---|
| Artiman Ventures | Palo Alto, USA / Bangalore, India | generalist | seedseries-a+1 | 1 |